These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 13736620)

  • 21. Determination of dehydrogenase activity of serum protein-fractions separated by paper-electrophoresis.
    BAJUSZ E; KOVARY L
    Yokohama Med Bull; 1957 Aug; 8(4):238-41. PubMed ID: 13558212
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electrophoresis and blood protein formula in arterial diseases].
    MOUQUIN M; HATT PY; MAILLART
    Arch Mal Coeur Vaiss; 1954 Nov; 47(11):881-5. PubMed ID: 14362667
    [No Abstract]   [Full Text] [Related]  

  • 23. D-dimer and inflammatory markers in the peripheral arterial disease.
    Moresco RN; Silla L
    Thromb Res; 2007; 119(6):797-8. PubMed ID: 16949137
    [No Abstract]   [Full Text] [Related]  

  • 24. [Peripheral circulatory disorders in expert testimony: current problems and pathogenetic and clinical fundamentals].
    KOSTER R
    Munch Med Wochenschr; 1958 May; 100(19):775-82. PubMed ID: 13565950
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
    Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
    Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis.
    Ferrero S
    J Clin Apher; 2004; 19(3):160; author reply 161. PubMed ID: 15493053
    [No Abstract]   [Full Text] [Related]  

  • 27. Double jeopardy: how soluble P-selectin activates leukocytes in peripheral arterial occlusive disease.
    Galkina E; Ley K
    Circ Res; 2006 Jan; 98(1):12-4. PubMed ID: 16397153
    [No Abstract]   [Full Text] [Related]  

  • 28. Vascular-endothelial growth factor (VEGF) in patients with peripheral ischemia.
    Proczka RM; Małecki M; Chorostowska-Wynimko J; Polański JA
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():305-11. PubMed ID: 17072059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is a simple biomarker for peripheral arterial disease on the horizon?
    Annex BH
    Circulation; 2007 Sep; 116(12):1346-8. PubMed ID: 17875981
    [No Abstract]   [Full Text] [Related]  

  • 30. [Apparatus for the treatment of peripheral circulatory disorders by means of arterial high pressure infusion].
    BRANDT H
    Dtsch Gesundheitsw; 1955 Apr; 10(15):555-7. PubMed ID: 14379831
    [No Abstract]   [Full Text] [Related]  

  • 31. [The circulatory disorders caused by noise. Vascular complications of the traumato-vibratory syndrome].
    REINHAREZ D
    Bull Soc Sci Med Grand Duche Luxemb; 1961 Jun; 98():281-6. PubMed ID: 13740609
    [No Abstract]   [Full Text] [Related]  

  • 32. [Surgical treatment of dermatoses due to circulatory disorders].
    KARFIK
    Cesk Dermatol; 1955 Feb; 30(1):12-7. PubMed ID: 14390539
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004.
    Perlstein TS; Pande RL; Beckman JA; Creager MA
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):166-72. PubMed ID: 17975120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained elevation of circulating vascular endothelial growth factor after percutaneous angioplasty for peripheral arterial diseases.
    Liu TJ; Lai HC; Ting CT; Lee WL
    Int J Cardiol; 2006 Mar; 107(3):415-6. PubMed ID: 16503265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New views on the treatment of venous circulatory disorders].
    WEYCHERT HA
    Z Haut Geschlechtskr; 1961 Nov; 31():261-3. PubMed ID: 14006407
    [No Abstract]   [Full Text] [Related]  

  • 36. [Organic & functional circulatory disorders].
    HAESE E
    Ther Ggw; 1958 May; 97(5):184-7. PubMed ID: 13569390
    [No Abstract]   [Full Text] [Related]  

  • 37. [Exploration and treatment of functional circulatory disorders of the extremities].
    PASSLER HW
    Angiologia; 1959; 11(2):95-9. PubMed ID: 13627551
    [No Abstract]   [Full Text] [Related]  

  • 38. [General data on local circulatory disorders].
    CASTAIGNE P
    Union Med Can; 1953 Dec; 82(12):76-8. PubMed ID: 13136611
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating CD40 ligand in peripheral arterial disease.
    Moresco RN; de Bem AF; da Silva JE
    Thromb Res; 2007; 120(5):781-2. PubMed ID: 17433826
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lacticemic curve after muscular work in chronic venous insufficiency of the lower extremities].
    GIUDICE A; MAIRANO C
    Minerva Chir; 1954 Dec; 9(24):1147-9. PubMed ID: 14355734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.